Senior Director
Akebia Therapeutics
Senior Director
Akebia Therapeutics
Develops CKD anemia therapies
The Senior Director, R&D Program Lead will lead the cross-functional development program for ebribafusp alfa (AKB-097), currently in Phase 2, and may assume responsibility for additional early-stage Akebia programs as they advance from research. This individual will set program strategy, align functional plans with corporate and portfolio objectives, and drive execution through key development milestones and decisions. The role requires strong drug-development expertise, strategic judgment, and the ability to lead and influence high-performing teams in a matrix environment.
Base Compensation for this role will depend on a number of factors including a candidate’s qualifications, skills, competencies, and experience, and may fall outside of the range shown. Base pay is only one component of the company’s total rewards package, all regular employees are also eligible for the corporate bonus program or the incentive compensation program (if applicable), as well as equity. Additional benefits include health care, vision, dental, retirement, PTO, etc.
Targeted Base Salary 249811 - 308590 USD
Develops CKD anemia therapies
Akebia Therapeutics focuses on developing and commercializing therapies for chronic kidney disease (CKD), especially anemia related to CKD. Its lead product candidate, vadadustat, is in global Phase 3 trials. The company conducts research, clinical development, and strategic partnerships to bring therapies to market, generating revenue from product sales, licensing, and collaborations. Akebia's goal is to improve the quality of life for CKD patients by providing effective treatments through a science-driven biopharmaceutical approach based in Cambridge, MA.
Explore more opportunities at Akebia Therapeutics